COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,441 Articles (22,835 medRxiv, 8,606 bioRxiv)

Most recent first Previous |  Page 1661: Articles 16601-16610  | Next

Mutations in the B.1.1.7 SARS-CoV-2 spike protein reduce receptor-binding affinity and induce a flexible link to the fusion peptide
Socher, E., Conrad, M., Heger, L., Paulsen, F., Sicht, H., Zunke, F., Arnold, P.
10.1101/2021.04.06.438584 — Posted: 2021-04-06
Interactions of SARS-CoV-2 envelope protein with amilorides correlate with antiviral activity
Park, S. H., Siddiqi, H., Castro, D., De Angelis, A., Oom, A. L., Stoneham, C., Lewinski, M., Clark, A., Croker, B., Carlin, A., Guatelli, J., Opella, S. J.
10.1101/2021.04.06.438579 — Posted: 2021-04-06
Brain Functional Connectivity Scans, Acquired Years Before the Pandemic, Predict COVID-19 Infections in Older Adults: Data From 3,662 Participants
Abdallah, C.
10.1101/2021.04.01.21254709 — Posted: 2021-04-06
Drug repositioning candidates identified using in-silico quasi-quantum molecular simulation demonstrate reduced COVID-19 mortality in 1.5M patient records
Alamgir, J., Yajima, M., Ergas, R., Chen, X., Hill, N., Munir, N., Saeed, M., Gersing, K., Haendel, M., Chute, C., Abid, R.
10.1101/2021.03.22.21254110 — Posted: 2021-04-06
Antibody response to SARS-CoV-2 mRNA vaccines in pregnant women and their neonates
Prabhu, M., Murphy, E. A., Sukhu, A. C., Yee, J., Singh, S., Eng, D., Zhao, Z., Riley, L. E., Yang, Y. J.
10.1101/2021.04.05.438524 — Posted: 2021-04-06 Discussion: Onsite
Uneven growth of SARS-CoV-2 clones evidenced by more than 500,000 whole-genome sequences
Zeng, H.-L., Liu, Y., Thorell, K., Norden, R., Aurell, E.
10.1101/2021.04.06.437914 — Posted: 2021-04-06
Altered O-glycosylation Level of SARS-CoV-2 Spike Protein by Host O-glycosyltransferase Strengthens Its Trimeric Structure
Xu, Z., Ku, X., Tian, J., Zhang, H., Hou, J., Zhang, C., Shi, J., Li, Y., Kaji, H., Tao, S.-c., Kuno, A., Yan, W., Da, L.-T., Zhang, Y.
10.1101/2021.04.06.438614 — Posted: 2021-04-06
Ageing impairs the airway epithelium defence response to SARS-CoV-2
Capraro, A., Wong, S. L., Adhikari, A., Allan, K. M., Patel, H. R., Zhong, L., Raftery, M., Jaffe, A., Yeang, M., Aggarwal, A., Wu, L., Pandzic, E., Whan, R. M., Turville, S., Vittorio, O., Bull, R. A., Kaakoush, N., Rawlinson, W. D., Tedla, N., Vafaee, F., Waters, S. A.
10.1101/2021.04.05.437453 — Posted: 2021-04-06
ADNKA overcomes SARS-CoV2-mediated NK cell inhibition through non-spike antibodies
Fielding, C. A., Sabberwal, P., Williamson, J. C., Greenwood, E. J., Crozier, E., Zelek, W., Seow, J., Graham, C., Huettner, I., Edgeworth, J., Morgan, B. P., Ladell, K., Eberl, M., Humphreys, I. R., Merrick, B., Doores, K. J., Wilson, S. J., Lehner, P. J., Wang, E., Stanton, R. J.
10.1101/2021.04.06.438630 — Posted: 2021-04-06
High-Potency Polypeptide-based Interference for Coronavirus Spike Glycoproteins
Ma, J., Campos Acevedo, A., Wang, Q.
10.1101/2021.04.05.438537 — Posted: 2021-04-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).